New on NCI Websites for October 2016

An NCI Cancer Currents blog post that provides updates on new NCI websites and other online content of interest to...

Metabolomics Study Reveals another Energy Source for Cancer Cells

Researchers have found that cancer cells can use the compound lactate to fuel biochemical reactions and to generate other compounds...

Modified Immunotherapy Approach Shows Promise for Leukemia

Researchers have developed an immunotherapy approach that uses immune cells whose natural cancer killing abilities have been enhanced in the...

DINO RNA Molecule Triggers Anticancer Response in Damaged Cells

Studies in cells and mice found that, in cells with damaged DNA, a noncoding RNA called DINO stabilizes the p53...

‘Unexpected’ Vulnerability Creates Treatment Opportunity in Aggressive Type of Lung Cancer

A new study has identified a potentially critical vulnerability in lung cancers that have mutations in the KRAS gene, and...

Scientists Identify Potential Marker of Resistance to PARP Inhibitors

Findings from a new study from NCI researchers could help predict whether a tumor will respond to a new class...

Olaratumab Approved to Treat Advanced Soft Tissue Sarcoma

The Food and Drug Administration (FDA) has granted accelerated approval to olaratumab (Lartruvo®) for the treatment of some patients with...

Symposium Brings Rising Global Cancer Burden into Focus

An NCI Cancer Currents blog post about the NCI Global Cancer Research Symposium, which examined ways of increasing research collaboration,...

Connected Health: An Important Tool for Making Progress against Cancer

A new report from the President’s Cancer Panel outlines how connective technologies can promote cancer prevention, enhance patients’ treatment experience,...